[Pharmacokinetics of the principal anti-arrhythmia agents].
D000319:Adrenergic beta-Antagonists / Q000378:metabolism; D000404:Ajmaline / Q000378:metabolism; D000638:Amiodarone / Q000378:metabolism; D000889:Anti-Arrhythmia Agents / Q000378:metabolism*; D001073:Aprindine / Q000378:metabolism; D001950:Bretylium Tosylate / Q000378:metabolism; D004206:Disopyramide / Q000378:metabolism; D006801:Humans; D008801:Mexiletine / Q000378:metabolism; D010672:Phenytoin / Q000378:metabolism; D011342:Procainamide / Q000378:metabolism; D011433:Propranolol / Q000378:metabolism; D011802:Quinidine / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000404:Ajmaline; D008801:Mexiletine; D001073:Aprindine; D010672:Phenytoin; D001950:Bretylium Tosylate; D011433:Propranolol; D004206:Disopyramide; D011802:Quinidine; D011342:Procainamide; D000638:Amiodarone
Pharmacocinétique des principaux anti-arythmiques.